about
Development of an Enhanced Sensitivity Bead-Based Immunoassay for Real-Time In Vivo Detection of Pancreatic β-Cell DeathPreexisting insulin autoantibodies predict efficacy of otelixizumab in preserving residual β-cell function in recent-onset type 1 diabetesPotential of UCHL1 as biomarker for destruction of pancreatic beta cells.Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients.An analytical comparison of three immunoassay platforms for subpicomolar detection of protein biomarker GAD65.
P50
description
researcher (ORCID 0000-0001-5099-8962)
@en
wetenschapper
@nl
name
Katrijn Verhaeghen
@en
Katrijn Verhaeghen
@nl
type
label
Katrijn Verhaeghen
@en
Katrijn Verhaeghen
@nl
prefLabel
Katrijn Verhaeghen
@en
Katrijn Verhaeghen
@nl
P31
P496
0000-0001-5099-8962